Surgical Science Sweden AB (publ) (STO:SUS)

Market Cap	1.57B -78.1%
Revenue (ttm)	992.34M +12.2%
Net Income	66.82M -49.2%
EPS	1.31 -49.2%
Shares Out	51.03M
PE Ratio	23.44
Forward PE	13.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,884
Average Volume	300,918
Open	31.98
Previous Close	30.70
Day's Range	30.92 - 31.98
52-Week Range	23.70 - 162.80
Beta	0.59
RSI	51.65
Earnings Date	May 20, 2026

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnosti...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 313
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SUS

Financial Performance

In 2025, STO:SUS's revenue was 992.34 million, an increase of 12.25% compared to the previous year's 884.09 million. Earnings were 66.82 million, a decrease of -49.24%.